The Need-to-Know on a Slow News Day: More MFN Deals Are Coming, and Why Pharma Thinks the U.S./U.K. Trade Agreement Should Be a Model

It’s a quick one today.  I’m on the road, attending the Oliver Wyman Health Innovation Summit. I had the opportunity to share the stage yesterday with ICER’s Sarah Emond, and

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.

I guess I’m supposed to write about the Senate HELP hearing yesterday. I’ve certainly wasted a bunch of pixels in the runup. It would be weird if I ignored it